Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Fort Worth TX, Irving TX, Houston TX, Kansas City MO,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Dallas TX, Tyler TX, Austin TX, San Antonio TX,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase 2, Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, San Antonio TX, Tulsa OK,
Sponsor: Kartos Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT05797831
Phase 2, Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Fort Worth TX, Dallas TX, Tyler TX, Abilene TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: Fort Worth TX, Kyle TX, Mobile AL, Cincinnati OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218341
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, in Adult Participants With Extensive-Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer (SCLC)
Location: Fort Worth TX, Arlington TX, Bedford TX, Grapevine TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07226999
Phase 2, Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Fort Worth TX, Arlington TX, Bedford TX, Dallas TX,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase 3, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Fort Worth TX, Tyler TX, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase 3, Recruiting
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Location: Fort Worth TX, Tyler TX, Austin TX, The Woodlands TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07776691
Phase 3, Recruiting
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Tyler TX, Austin TX, Shreveport LA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for
Solid Cancer
Location: Fort Worth TX, Oklahoma City OK, Houston TX, Tulsa OK,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06161025
Phase 2, Phase 3, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Fort Worth TX, Tyler TX, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Arlington TX, Fort Worth TX, Burleson TX, Bedford TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Fort Worth TX, Dallas TX, Tyler TX, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase 1, Recruiting
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
for
Endometrioid Endometrial Cancer
Location: Fort Worth TX, Dallas TX, Tucson AZ, Greenville SC,
Sponsor: Traws Pharma, Inc.
Sex: Female
Age: 18+
Code: NCT05705505
Phase 1, Phase 2, Recruiting
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
for
Ovarian Cancer Recurrent
Location: Fort Worth TX, Oklahoma City OK, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06843447
Phase 1, Phase 2, Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
for
Gastric Adenocarcinoma, Gastric Cancer,
Location: Fort Worth TX, Arlington TX, Bedford TX, Grapevine TX,
Sponsor: Toray Industries, Inc
Sex: All
Age: 18+
Code: NCT06038578
Phase 2, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Fort Worth TX, Bedford TX, Dallas TX, Austin TX,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT04831580
Recruiting
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
for
Hypochondroplasia
Location: Fort Worth TX, Columbia MO, Saint Louis MO, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0 - 15
Code: NCT06212947
Recruiting
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
for
Ulcerative Colitis
Location: Fort Worth TX, Abilene TX, Chicago IL, Orlando FL,